The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury
Valproic acid (VPA) is widely used as a major drug in the treatment of epilepsy. Despite the undisputed pharmacological importance and effectiveness of VPA, its potential hepatotoxicity is still a major concern. Being a simple fatty acid, the hepatotoxicity induced by VPA has long been considered to...
Gardado en:
Main Authors: | Yiyi Ma (Author), Minglu Wang (Author), Shuaishuai Guo (Author), Tong Li (Author), Xiaodong Liu (Author), Limei Zhao (Author) |
---|---|
Formato: | Libro |
Publicado: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
por: Yussra Ata Yaseen Abdulqader, et al.
Publicado: (2021) -
Platelet counts in epileptic children receiving valproic acid
por: Lilik Indrayati, et al.
Publicado: (2020) -
Valproic Acid-Associated Liver Failure
por: J Gordon Millichap
Publicado: (2011) -
Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients
por: Jingwei Zhu, et al.
Publicado: (2024) -
Valproic Acid and Thrombocytopenia
por: J Gordon Millichap
Publicado: (1996)